Retinal images can classify metabolic syndrome, a risk factor for cardiovascular disease and diabetes, using a Vision Transformer-based model. Combining retinal images with clinical features enhances ...

The FDA has granted Priority Review status to Regeneron’s and Bayer’s supplemental Biologics License Application (sBLA) for Eylea HD (aflibercept) injection 8 mg. The application seeks to expand use ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

EYLEA HD is a treatment for retinal vein occlusion (RVO) that allows for dosing every 8 weeks after initial monthly doses, potentially halving injections. What is the FDA's action date for EYLEA ...

for aflibercept injection 8mg for the treatment of macular edema following retinal vein occlusion (RVO) and monthly dosing across all approved indications. The sBLA was supported by data from the ...

The sBLA seeks approval for Eylea HD to treat patients with macular edema following retinal vein occlusion (RVO), and for broadening the dosing schedule to include every 4-week (monthly) dosing across ...

Less than half of patients who present to a US hospital’s emergency department with central retinal artery occlusion receive no stroke workup imaging, despite recommendations. Most patients in the ...

Andre Onana responded to Nemanja Matic calling him "one of the worst goalkeepers in Manchester United's history" by poking fun at the Lyon midfielder's lack of silverware at Old Trafford.

Elon Musk and Peter Navarro are engaged in a public dispute. The disagreement centered on the economic impact of Donald Trump's tariffs. Musk criticised the tariffs, blaming them for Tesla's ...

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular ...

Bayer seeks EMA approval to expand aflibercept 8 mg use for macular edema post retinal vein occlusion. Phase 3 QUASAR study data showed aflibercept 8 mg improved BCVA in patients with RVO, supporting ...